Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cholic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel sulfonyl chloride method for glycocholic acid ensures high purity and safety. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.
Patent CN112899191B reveals a green route from phytosterol to bile acids, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN106256833B details a cost-effective synthesis for Obeticholic Acid intermediates. Discover supply chain advantages and scalable manufacturing solutions.
Patent CN102766185A details a novel method for recovering ursodesoxycholic acid and chenodeoxycholic acid from waste mother liquor, offering significant cost reduction and supply chain reliability.
Discover a novel synthetic route for ursodesoxycholic acid from chenodeoxycholic acid featuring high optical purity and mild conditions for reliable pharmaceutical intermediate supply.
Novel hydrogenation process for Obeticholic Acid Type 1 reduces steps and improves purity. Ensures stable supply chain and cost efficiency for global pharmaceutical manufacturing partners.
Patent CN106868534B enables mild electro-catalytic synthesis. Delivers high-purity bile acids with substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel stigmasterol based UDCA preparation method ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing processes.
Novel hyocholic acid route for 7-Ketocholic acid ensures high purity and scalable production. Ideal for pharmaceutical intermediate supply chains seeking cost efficiency.
Novel chemical synthesis route for cholic acid intermediate A5 eliminates animal extraction risks. Offers scalable, high-purity pharmaceutical intermediates for global supply chains.
Novel 9-step synthesis for deoxycholic acid intermediates. Reduces steps, increases yield to 31.5%. Ideal for pharmaceutical supply chains and cost reduction.
Patent CN115856110B details a high-yield synthesis for 3α,7α-dihydroxy-6α-ethyl-5β-cholan-24-aldehyde, offering superior purity for pharmaceutical quality control and supply chain stability.
Novel synthesis of Cholic Acid Intermediate A4 via patent CN116023424B. Ensures high purity, avoids animal extraction risks, and offers scalable commercial production for global supply chains.
Patent CN105368828A enables high-yield UDCA synthesis via recombinant E. coli ensuring supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN105418716A details a novel duck bile extraction method for Chenodeoxycholic acid. This process ensures high purity and significant cost reduction for pharmaceutical intermediates manufacturing supply chains.
Patent CN105646634A details novel impurity synthesis routes ensuring high purity pharmaceutical intermediates supply chain stability and cost efficiency for global buyers.
Patent CN1912192B reveals a green electrochemical route for 7-keto lithocholic acid. Discover cost-effective manufacturing and reliable supply chain solutions.
Discover the advanced preparation method of Obeticholic Acid via patent CN111138509B, offering high purity, reduced impurities, and scalable manufacturing for global supply chains.
Patent CN110669091A reveals a novel DIPEA salt crystallization method for high-purity ursodeoxycholic acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced purification process for ursodeoxycholic acid ensures 99.8% purity. Optimized solvent usage reduces energy consumption for reliable pharmaceutical intermediate supply chains.